Register Login
Open Access Research Article

Formulation of Polymeric Multicomponent Systems Containing Cardiovascular APIs

Fawzia Sha’at, Ramona Daniela Pavaloiu, Daniela Crina Salceanu, Cristina Hlevca, Gheorghe Nechifor
Published 30 Mar 2018
Pages 121–123

Abstract

The main aim of this study was to prepare and characterize polymeric nanoparticles containing two cardiovascular active pharmaceutical ingredients: valsartan (VAL) and amlodipine besylate (AML). Six formulations were evaluated with different ratios of AML:VAL:PLGA (1:16:17, 1:16:34, and 1:16:51) and different stirring speed (1200 and 2400 rpm). Encapsulation efficiency (EE, %) and particle size analyses were performed to characterize and optimize the formulation. All loaded nanoparticles showed a high EE (%), nano-size, negative x-potential and a high homogeneity.

Keywords: nanotechnology; cardiovascular drugs; drug delivery systems; medicinal chemistry

How to Cite this Article

Sha’at, F., Pavaloiu, R., Salceanu, D., Hlevca, C., & Nechifor, G. (2018). Formulation of Polymeric Multicomponent Systems Containing Cardiovascular APIs. Materiale Plastice, 55(1), 121–123. https://doi.org/10.37358/MP.18.1.4976
Sha’at F, Pavaloiu R, Salceanu D, Hlevca C, Nechifor G. Formulation of Polymeric Multicomponent Systems Containing Cardiovascular APIs. Materiale Plastice. 2018;55(1):121–123. doi: 10.37358/MP.18.1.4976
F. Sha’at, R. Pavaloiu, D. Salceanu, C. Hlevca, and G. Nechifor, "Formulation of Polymeric Multicomponent Systems Containing Cardiovascular APIs,” Materiale Plastice, vol. 55, no. 1, pp. 121–123, 2018. doi: 10.37358/MP.18.1.4976
✓ Copied to clipboard